Reactivation in major organ involvement following SARS-CoV-2 mRNA vaccination in Behçet's syndrome patient receiving immunosuppressive therapy.

Yildirim, Resit; Üsküdar Cansu, Döndü; Dinler, Mustafa; Korkmaz, Cengiz

Yildirim, Resit; Üsküdar Cansu, Döndü; Dinler, Mustafa; Korkmaz, Cengiz.

Yildirim R; Division of Rheumatology, Department of Internal Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey.
Üsküdar Cansu D; Division of Rheumatology, Department of Internal Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey.
Dinler M; Division of Rheumatology, Department of Internal Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey.
Korkmaz C; Division of Rheumatology, Department of Internal Medicine, Eskisehir Osmangazi University, Eskisehir, Turkey.

Rheumatology (Oxford) ; 61(SI2): SI197-SI199, 2022 06 28.

Article in English | MEDLINE | ID: covidwho-1853214

Subject(s)

Behcet Syndrome; COVID-19; Behcet Syndrome/drug therapy; COVID-19/prevention & control; Humans; Immunosuppression Therapy; RNA, Messenger; SARS-CoV-2; Vaccination

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Behcet Syndrome / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: Rheumatology (Oxford) Journal subject: Rheumatology Year: 2022 Document Type: Article Affiliation country: Rheumatology

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google